All In Biotech

Drug Trial Radar · NCT00684970

Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

A Phase IIB Clinical Trial of the Anti-Angiogenic Drug Combination Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

Last checked: Nov 19, 2026Latest source record: Dec 5, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Mar 2009

Primary completion

Feb 2014

Sponsor

Lead sponsor
Tiltan Pharma Ltd.Industry
Sponsor type
Industry
First posted
May 28, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Hamsa-1™ is an anti-angiogenic drug combination designed for the treatment of cancer. The investigational product Hamsa-1™ comprises of four well-known active components. The therapy is administrated at a unique dosing regimen that was found to be effective and advantageous in terms of safety.The product is formulated as an oral suspension, conveniently administrated by the patients at home and not requiring medical staff assistance. This Phase IIb clinical trial aims to evaluate the efficacy of Hamsa-1™ for the treatment of metastatic Castration Resistant Prostate Cancer (CRPC) patients.

Conditions

  • Metastatic Castration Resistant Prostate Cancer (CRPC)

Interventions

  • Hamsa-1™ TL-118Drug

    Once daily Hamsa-1™ TL-118

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survival (PFS) measured 24 weeks after treatment initiationTime frame: 24 weeks and up to 3 years

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Bnei Tzion Medical Center

    Haifa, Israel · Recruiting

  • Rambam Medical Center

    Haifa, Israel · Recruiting

  • Sourasky Medical Center

    Tel Aviv, Israel · Recruiting

  • Sheba Medical Center

    Tel HaShomer, Israel · Recruiting

  • Asaf Harofe Medical Center

    Tzrifin, Israel · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.